SVE — Synthaverse SA Share Price
Last trade - 00:00- PLN314.58m
- PLN391.53m
- PLN58.61m
- 32
- 13
- 77
- 31
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 14.82 | ||
| PEG Ratio (f) | 0.22 | ||
| EPS Growth (f) | 200% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.77 | ||
| Price to Tang. Book | 2.79 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 5.02 | ||
| EV to EBITDA | 23.76 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.69% | ||
| Return on Equity | 4.02% | ||
| Operating Margin | 14.64% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | PLNm | 39.11 | 40.16 | 41.15 | 50.38 | 58.61 | 63.4 | 102.2 | 12.66% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +82.08 | -1.47 | +24.77 | -19.46 | +25.94 | +200 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Synthaverse SA formerly known as Biomed Lublin Wytwornia Surowic i Szczepionek SA is a Poland-based company operating in the Life Science industry, dealing primarily with the production of medicines. The Company focuses on the production of drugs in the field of immunotherapy. Synthaverse SA offers its services in the field such as: oncological immunotherapy, Immunotherapy in Serological Conflict, Passive immunotherapy in hepatitis B, Active anti-tuberculosis immunotherapy, Gynecology and Proctology, Probiotics, Laboratory reagents. The Company offers injection drugs, lyophilisates of active substances in sterile sealed vials, active substances and drugs based on surface and submerged biological culture, suppository forms of drugs. The Company supplies its products to 50 countries around the world.
Directors
- Jaroslaw Blaszczak CSU
- Piotr Fic CMG (52)
- Wiktor Napiora VSU (62)
- Katarzyna Krukowska CAO
- Waldemar Sierocki SEC (63)
- Konrad Miterski IND (47)
- Dirk Pamperin IND (52)
- Dariusz Kucowicz SUB (53)
- Piotr Kwasniewski SUB
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- December 13th, 2010
- Public Since
- July 29th, 2011
- No. of Employees
- 239
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Warsaw Stock Exchange
- Shares in Issue
- 70,770,575
- Address
- ul. Uniwersytecka 10, LUBLIN, 20-029
- Web
- https://synthaverse.pl/
- Phone
- +48 815338221
- Auditors
- UHY ECA Audyt Sp. Zoo SP. k.
Upcoming Events for SVE
Similar to SVE
7Fit SA
Warsaw Stock Exchange
Bioceltix SA
Warsaw Stock Exchange
Biogened SA
Warsaw Stock Exchange
Cannabis Poland SA
Warsaw Stock Exchange
Celon Pharma SA
Warsaw Stock Exchange
FAQ
As of Today at 23:32 UTC, shares in Synthaverse SA are trading at PLN4.45. This share price information is delayed by 15 minutes.
Shares in Synthaverse SA last closed at PLN4.45 and the price had moved by -7.15% over the past 365 days. In terms of relative price strength the Synthaverse SA share price has underperformed the FTSE Global All Cap Index by -9.47% over the past year.
The overall consensus recommendation for Synthaverse SA is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreSynthaverse SA does not currently pay a dividend.
Synthaverse SA does not currently pay a dividend.
Synthaverse SA does not currently pay a dividend.
To buy shares in Synthaverse SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of PLN4.45, shares in Synthaverse SA had a market capitalisation of PLN314.58m.
Here are the trading details for Synthaverse SA:
- Country of listing: Poland
- Exchange: WSE
- Ticker Symbol: SVE
Based on an overall assessment of its quality, value and momentum Synthaverse SA is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Synthaverse SA is PLN6.50. That is 46.23% above the last closing price of PLN4.45.
Analysts covering Synthaverse SA currently have a consensus Earnings Per Share (EPS) forecast of PLN0.10 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Synthaverse SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +1.69%.
As of the last closing price of PLN4.45, shares in Synthaverse SA were trading -3.71% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Synthaverse SA PE ratio based on its reported earnings over the past 12 months is 14.82. The shares last closed at PLN4.45.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Synthaverse SA's management team is headed by:
- Jaroslaw Blaszczak - CSU
- Piotr Fic - CMG
- Wiktor Napiora - VSU
- Katarzyna Krukowska - CAO
- Waldemar Sierocki - SEC
- Konrad Miterski - IND
- Dirk Pamperin - IND
- Dariusz Kucowicz - SUB
- Piotr Kwasniewski - SUB